植物医生IPO：以“1中心5基地”的科研架构，筑牢国妆核心竞争力

Core Insights - The long-term vitality of the brand is rooted in differentiated core competitiveness, emphasizing the need to build unique value barriers to cultivate a trust-based consumer group [1] - DR PLANT, a brand focused on high-altitude plant skincare, is set to launch an IPO on the Shenzhen Stock Exchange, driven by its brand strategy of "high-altitude plants, pure beauty" and systematic research capabilities [1] Research and Development - The foundation of the brand's competitiveness lies in its deep commitment to research, having established the "Chinese Academy of Sciences Kunming Plant Research Institute R&D Center" in 2014 to conduct systematic studies on high-altitude plant skincare [3] - High-altitude plants possess strong resistance and higher active substance content compared to ordinary plants, aligning with modern consumer demands for "pure beauty" [3] - The brand combines traditional Chinese herbal essence with modern technology, achieving global recognition with products like Dendrobium and Qingci fruit, and has been certified as the "global leader in Dendrobium skincare retail sales" by Euromonitor [3] R&D Infrastructure - The research system has evolved into a "1 center + 5 bases" structure, covering the entire chain from basic research to industrial application [4] - The Tokyo R&D center, established in 2016, serves as an "international bridge," integrating advanced extraction technologies from Japan with Chinese high-altitude plant resources to develop customized products for overseas markets [4] - As of October 31, 2025, this system has generated 223 patents, with the "Key Technology Research and Industrial Application of Dendrobium Active Extract" project winning a national award for commercial technological progress, showcasing industry-leading capabilities [4] Market Channels - The brand has established a unique "experience + sales + service" model through a dense network of 4,269 offline stores, enhancing the synergy between research, products, and channels [6] - The brand has received recognition as the "number one single-brand cosmetics store in China" and has gained loyal users in overseas markets such as Japan and Indonesia [6] IPO and Future Plans - The IPO aims to raise funds, with 260 million yuan earmarked for upgrading the R&D center to further strengthen technological barriers [7] - The brand views the IPO as a new starting point to continuously activate its research potential and deepen its global layout in the single-brand store sector [9] - This research-driven development path injects substantial growth momentum into the brand and propels domestic beauty products from price competition to value competition [9]